A study that teases apart the biological mechanisms by which human papillomaviruses (HPV) cause cancer has found what researchers at Georgetown University Medical Center say is a new strategy that might provide targeted treatment for these cancers.
It is often claimed that people who are bilingual are better than monolinguals at learning languages. Now, the first study to examine bilingual and monolingual brains as they learn an additional language offers new evidence that supports this hypothesis, researchers say.
Georgetown University’s Center for Global Health Science and Security announces the launch of a free, web-based tool that allows national leaders to calculate costs of developing the capacity to prevent, detect, and respond to public health threats.
Researchers have found cell receptors abnormally overexpressed in post-mortem brains of those with Parkinson’s and Alzheimer’s diseases, and that they can be inhibited in animal models to clear toxic protein buildup, reduce brain inflammation, and improve cognitive performance.
Georgetown University Medical Center (GUMC) has named Mark Dybul, MD, as the inaugural faculty director of its new Center for Global Health and Quality.
Acute and chronic infections in a person’s upper gastrointestinal tract appear to be linked to Parkinson’s disease, say scientists at Georgetown University Medical Center and their collaborators at the National Institutes of Health and other institutions.
Rebecca Katz, PhD, MPH, co-director of the Center for Global Health Science and Security at Georgetown University Medical Center, will testify before a subcommittee of the U.S. Senate Committee on Foreign Relations examining the role of U.S. support for the World Health Organization.
In the first study of its kind, researchers say male mice have much greater brain distress in the week following a traumatic brain injury (TBI) than female mice, including skyrocketing inflammation and nerve cell death.
Georgetown University today announces it has exclusively licensed worldwide intellectual property (IP) rights to develop and commercialize uses of tyrosine kinase (TK) inhibitors for the treatment of neurodegenerative diseases to Axovant Sciences GmbH.
Georgetown University Medical Center autism specialists working with Latino families in Washington, DC, have developed an effective screening program that identifies Latino infants who may be at risk for autism spectrum disorder (ASD), allowing the opportunity for early intervention.
Of the 1,000 GI cancer patients seen at his clinic last year, nearly half were under age 50, says John L. Marshall, MD, director of the Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center and chief of hematology and oncology at MedStar Georgetown University Hospital. Many are in their 20s and 30s; one was just 17.
A Georgetown physician-researcher has launched a first-of-its-kind study to test a medical care model that could change the way people with multiple sclerosis (MS) are treated.
How do factors such as race, culture, issues with accessing legal representation, and resiliency contribute to injustices for Native Americans? These are some of the issues to be discussed at a panel at Georgetown University titled "Justice in America for Native Americans."
“Urban Health: A Global Challenge" is a free satellite session on April 6, organized by Georgetown University, the International Society for Urban Health, and the New York Academy of Medicine. The session precedes the 2017 Annual CUGH Global Health Conference in Washington, DC.
The Open Philanthropy Project has awarded a $3.5 million grant to the Center for Global Health Science and Security at Georgetown University Medical Center to support research focused on improving U.S. and international biosecurity and pandemic preparedness policy.
Georgetown scientist and author Timothy Jorgensen looks back at the machine that changed the way we eat.
Georgetown researcher Peter Turkeltaub, MD, PhD, is awarded the Norman Geschwind Prize given annually by the American Academy of Neurology.
Georgetown University Medical Center today announces the launch of a phase II clinical trial to study the safety of the cancer drug nilotinib and its effects on clinical outcomes and biomarkers in people with Parkinson’s disease.
A recent survey suggests that many researchers have tried and failed to reproduce other scientists' experiments as well as their own. Georgetown University’s Rochelle Tractenberg, PhD, is on a mission to help change that by promoting ethical statistical practices. She’ll lead a panel discussion on the topic Sunday at the AAAS meeting in Boston.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right